Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 9.80
0.00 (0.00%)
At close: Oct 1, 2026
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 56.52 million as of October 1, 2026. Its market cap has decreased by -52.20% in one year.
Market Cap
56.52M
Enterprise Value
196.84M
Revenue
397.23K
Ranking
n/a
PE Ratio
n/a
Stock Price
9.80
ChartMarket Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 56.52M, a decrease of -76.50%. That is a compound annual growth rate of -26.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 56.52M | -60.33% |
| Dec 30, 2025 | 142.46M | -2.32% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
| Feb 10, 2022 | 240.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 6.11B |
| Idorsia | 1.19B |
| Basilea Pharmaceutica AG | 832.02M |
| Santhera Pharmaceuticals Holding AG | 231.01M |
| Newron Pharmaceuticals | 172.88M |
| BioVersys AG | 155.43M |
| Molecular Partners AG | 126.79M |
| MindMaze Therapeutics Holding | 25.13M |